Biomarkers For Biological Aging In Postmenopausal Women
As we age, our bodies undergo a natural decline in function, a process known as biological aging, which can progress differently from our chronological age. For women, a significant life transition, menopause, plays a crucial role in shaping this biological aging trajectory. The changes experienced during menopause, such as the loss of estrogen, shifts in body composition, persistent low-grade inflammation, and modifications in how our genes are expressed (known as epigenetic regulation), all contribute to how quickly our bodies age. These factors can lead to a wide range of health outcomes, affecting the heart and blood vessels, bones, brain function, and overall physical capabilities.
Scientists are actively working to quantify these complex processes using various tools. For instance, “phenotypic age” is a measure of biological age derived from a combination of a person’s actual age and several clinical markers, often from blood tests. Another innovative approach involves “epigenetic clocks,” which estimate biological age by analyzing specific chemical tags on our DNA. These tags, which are part of epigenetic regulation, don’t change our genetic code but influence how our genes are turned on or off.
While these biomarkers offer valuable insights into the mechanisms connecting menopause with biological aging and help explain various health outcomes, it’s important to note that currently, no single biological aging test has a widely accepted threshold for guiding routine menopause care. Research also suggests that postmenopausal status, particularly if menopause occurs early or through surgery, is linked to accelerated biological aging, indicated by markers like faster epigenetic aging and shorter protective caps on our chromosomes called telomeres. Interestingly, some studies indicate that hormone therapy might positively influence certain aging markers and reduce the difference between a woman’s biological and chronological age.
Ongoing research aims to further understand these connections, with a focus on tracking diverse groups of women through the menopausal transition to see how changes in these aging markers predict future health and responses to treatments. This work is vital for developing better strategies to promote healthy aging in women.
Source: link to paper